Nasdaq
$28.90▼ 0.24%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $2.26BShares out 78.3M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
16- 10.16After-hours26.10.17 05:564Ownership#●●●
Progyny, Inc.
Progyny, Inc. insider Melissa B. Cummings filed a Form 4 report on October 16, 2026, disclosing changes in beneficial ownership of securities that occurred on October 14, 2026.…more
$28.90-0.24%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 10.14Regular26.10.15 02:51144Ownership
Progyny, Inc.
Melissa B. Cummings, an insider at Progyny, Inc., has filed a Form 144 to report the proposed sale of company shares. This is a standard disclosure regarding an insider's plan to dispose of equity holdings.…more
$28.90-0.24%vs prev closeView filingShare - 9.28After-hours26.09.29 05:304Ownership
Progyny, Inc.
Progyny, Inc. insider Allison Swartz filed a Form 4 report regarding a change in beneficial ownership of securities as of September 23, 2026. This filing serves as a standard disclosure of insider equity transactions and does not indicate any material changes to the company's financial position or corporate governance.…more
$28.90-0.24%vs prev closeView filingShare
15 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 3d agoRegular26.10.21 23:43#●●●
Progyny Announces Third Quarter 2026 Earnings Release Date
Progyny will report its financial results for the third quarter of 2026 after the market closes on November 4, 2026. The company will host a conference call to discuss its quarterly performance and provide updates.…more
$28.90-0.24%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
- 10.15Regular26.10.15 22:34
●●●●●●●● ●●●●● ●●●●●●
Progyny will present research on the real-world symptom improvement of its menopause and midlife program at The Menopause Society 2026 Annual Meeting. This presentation highlights the company's clinical focus but does not have an immediate material impact on financial performance.…more
$28.90-0.24%vs prev close - 10.7Pre-market26.10.07 21:31
●●●●●●●● ●●●●● ●●●●●●
Progyny expects to add 1.2 million new covered lives by the first half of 2027, including anticipated contract decisions. This projection reflects the company's expected growth in its client base over the coming years.…more
$28.90-0.24%vs prev closeShareBenzinga
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report